spiral.imperial.ac.uk

(2016) Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment. Science . 353, 1033–1036. 16 Flasche, S. et al. (2016) The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine … ................
................

In order to avoid copyright disputes, this page is only a partial summary.